BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Michael S. Borofsky, Timothy Ito, Andrew B. Rosenkrantz, Samir S. Taneja. Focal therapy for prostate cancer – where are we in 2011?Therapeutic Advances in Urology 2011; 3(4): 183 doi: 10.1177/1756287211418724
2
Matthias C. Roethke, Michaela Kniess, Sascha Kaufmann, Matthias P. Lichy, Heinz-Peter Schlemmer, Arnulf Stenzl, David Schilling. Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer?World Journal of Urology 2014; 32(2): 379 doi: 10.1007/s00345-013-1106-3
3
D Gabriele, G Cattari, C Fiorito, M T Carchedi, E Garibaldi. Data collection for models validation: Application to prostate cancer — Clinical aspectsIEEE-EMBS International Conference on Biomedical and Health Informatics (BHI) 2014; : 5 doi: 10.1109/BHI.2014.6864290
4
Ingrid Mocikova, Jozef Babela, Vladimir Balaz. Prostate cancer - the role of magnetic resonance imagingBiomedical Papers 2012; 156(2): 103 doi: 10.5507/bp.2012.025
5
Naveen M. Kulkarni, Daniella F. Pinho, Srikala Narayanan, Avinash R. Kambadakone, Jeremy S. Abramson, Dushyant V. Sahani. Imaging for Oncologic Response Assessment in LymphomaAmerican Journal of Roentgenology 2017; 208(1): 18 doi: 10.2214/AJR.16.16180
6
F. Luyckx, P. Hallouin, C. Barré, G. Aillet, P. Chauveau, J.-F. Hétet, O. Bouchot, J. Rigaud. Cancer de la prostate localisé : l’IRM endorectale à 1,5 Tesla améliore-t-elle la sélection des patients en vue d’une surveillance active ?Progrès en Urologie 2011; 21(2): 114 doi: 10.1016/j.purol.2010.06.010
7
Gert O. De Meerleer, Piet Ost, Geert M. Villeirs, Nicolaas Lumen, Valérie Fonteyne. Prostate Cancer: A Comprehensive Perspective2013; : 709 doi: 10.1007/978-1-4471-2864-9_60